Advertisement
RayBiotech
RayBiotech

Alcoholism treatment

NEW YORK, August 25 (Praxis Press). Early-onset alcoholism (before age 25 years) is associated with serotonergic dysfunction, and individuals with early-onset alcoholism may be responsive to treatment with a selective serotonergic agent. To compare the effectiveness of ondansetron, a selective serotonin receptor antagonist, in the treatment of early-onset and late-onset alcoholism, Johnson and colleagues performed a double blind, randomized, placebo-controlled clinical trial. A total of 321 pati

August 25, 2000

NEW YORK, August 25 (Praxis Press). Early-onset alcoholism (before age 25 years) is associated with serotonergic dysfunction, and individuals with early-onset alcoholism may be responsive to treatment with a selective serotonergic agent. To compare the effectiveness of ondansetron, a selective serotonin receptor antagonist, in the treatment of early-onset and late-onset alcoholism, Johnson and colleagues performed a double blind, randomized, placebo-controlled clinical trial. A total of 321 patients with diagnosed alcoholism (mean age 40.6 years; 70.5% male; 78.6% white) were enrolled, 271 of whom were selected for the study. Patients were randomly assigned to receive 11 weeks of treatment with three different doses of ondansetron, (1, 4, and 16 micrograms/kg twice per day), or a placebo (n = 56). All patients also participated in weekly sessions of standardized group cognitive-behavioral therapy. The researchers found that participants with early-onset alcoholism who received ondansetron consumed fewer drinks per day and had a lower plasma carbohydrate deficient transferrin (CDT) level, an objective and sensitive marker of transient alcohol consumption, than the controls or than those with late-onset alcoholism, particularly those receiving a dose of 4 micrograms/kg twice per day. Ondansetron may be an effective treatment for patients with early-onset alcoholism, presumably ameliorating an underlying serotonergic abnormality.

Advertisement
Advertisement

Popular Now

  1. Opinion: Too Many Mitochondrial Genome Papers
  2. Antibiotics and the Gut Microbiome
  3. Sex Differences in Pain Pathway
  4. The Brain on Fear
    The Scientist The Brain on Fear

    Scientists uncover the neurons in the mouse brain responsible for linking the sight of a looming object to scared behavior.

Advertisement
The Scientist